Tvardi Therapeutics Inc. (TVRD)
NASDAQ: TVRD
· Real-Time Price · USD
31.11
0.67 (2.20%)
At close: Sep 05, 2025, 3:59 PM
2.20% (1D)
| Bid | 29.52 |
| Market Cap | 291.7M |
| Revenue (ttm) | 6.58M |
| Net Income (ttm) | -20.89M |
| EPS (ttm) | -2.25 |
| PE Ratio (ttm) | -13.83 |
| Forward PE | -7.95 |
| Analyst | Buy |
| Ask | 32 |
| Volume | 13,366 |
| Avg. Volume (20D) | 51,108 |
| Open | 31.88 |
| Previous Close | 30.44 |
| Day's Range | 30.24 - 31.88 |
| 52-Week Range | 8.14 - 34.31 |
| Beta | 0.25 |
About TVRD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TVRD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TVRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.07%
Tvardi Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 months ago
+14.78%
Tvardi Therapeutics shares are trading higher after the company announced it completed the enrollment for its phase 2 clinical trial of TTI-101.
